Infection
Symposium
New therapies for chronic respiratory infections
Translational
Aims : The aim of this session is to give the audience a general overview of the new therapies for chronic respiratory infections, including antibiotic therapy for patients with bronchiectasis and the new drugs for non-tuberculous mycobacteria and COPD.
Target audience :
Clinician, Fellow, General practitioner, Junior member, Microbiologist, Patient, Pharmaceutical industry representative, Pulmonologist, Researcher, Resident, Respiratory physician, Scientist, Student, Trainee
14:45
Understanding the concept of chronic infection in the microbiome era
F. Martinez(New York, United States)
COI
1
2990
15:15
How to tackle anti-microbial resistance
H. Goossens(Edegem (Antwerp), Belgium)
COI
2
2991
15:45
Managing chronic infection in COPD patients
M. van der Eerden(Rotterdam, Netherlands)
COI
3
2992
16:15
The management of non-tuberculous mycobacteria
M. Loebinger(London, United Kingdom)
COI
4
2993
. . .
